Nuo Therapeutics, Inc. (AURX) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $3.31M | +142.7% |
| 2024 | $1.37M | +124.3% |
| 2023 | $608.5K | +442.1% |
| 2022 | $112.2K | — |
| 2021 | $0 | — |
| 2020 | $0 | -100.0% |
| 2019 | $146.2K | -89.3% |
| 2018 | $1.37M | +90.1% |
| 2017 | $721.0K | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $3.31M | +142.7% |
| 2024 | $1.37M | +124.3% |
| 2023 | $608.5K | +442.1% |
| 2022 | $112.2K | — |
| 2021 | $0 | — |
| 2020 | $0 | -100.0% |
| 2019 | $146.2K | -89.3% |
| 2018 | $1.37M | +90.1% |
| 2017 | $721.0K | — |